Temporal changes in phosphatidylserine expression and glucose metabolism after myocardial infarction: An in vivo imaging study in mice

Molecular Imaging

Volumn 11, Issue 6, 2012, Pages 461-470

  Lehner, Sebastian ^b   Todica, Andrei ^b   Brunner, Stefan ^b   Uebleis, Christopher ^b   Wang, Hao ^b   Wängler, Carmen ^b   Herbach, Nadja ^b   Herrler, Tanja ^b   Böning, Guido ^b   Laubender, Rüdiger Paul ^b   Cumming, Paul ^b   Schirrmacher, Ralf ^b   Franz, Wolfgang ^b   Hacker, Marcus ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANNEXIN A5; APOPTOSIS RATES; CELL VIABILITY; FDG UPTAKES; FDG-PET; FLUORODEOXYGLUCOSE; GLUCOSE METABOLISM; IN-VIVO; IN-VIVO IMAGING; LEFT ANTERIOR DESCENDING ARTERIES; MYOCARDIAL INFARCTION; OPTIMAL TIME; PHOSPHATIDYLSERINE; POSITRON EMISSION TOMOGRAPHY (PET); TEMPORAL CHANGE; THERAPY MONITORING;

GALLIUM; GLUCOSE; MAMMALS; METABOLISM; PHYSIOLOGY; POSITRON EMISSION TOMOGRAPHY; RADIOGRAPHY; TISSUE;

ANTIBIOTICS;

FLUORODEOXYGLUCOSE F 18; GALLIUM; GLUCOSE; LIPOCORTIN 5; PHOSPHATIDYLSERINE;

ANIMAL; ARTICLE; AUTORADIOGRAPHY; C57BL MOUSE; FEMALE; HEART INFARCTION; METABOLISM; MOUSE; POSITRON EMISSION TOMOGRAPHY; SCINTISCANNING;

ANIMALS; ANNEXIN A5; AUTORADIOGRAPHY; FEMALE; FLUORODEOXYGLUCOSE F18; GALLIUM RADIOISOTOPES; GLUCOSE; MICE; MICE, INBRED C57BL; MYOCARDIAL INFARCTION; PHOSPHATIDYLSERINES; POSITRON-EMISSION TOMOGRAPHY;

EID: 84873897676     PISSN: 15353508     EISSN: None     Source Type: Journal    
DOI: 10.2310/7290.2012.00010     Document Type: Article

References (32)

1. Fliss H, Gattinger D. Apoptosis in ischemic and reperfused rat myocardium. Circ Res 1996;79:949-56, doi:10.1161/01.RES.79. 5.949.
2. Brunner S, Winogradow J, Huber BC, et al. Erythropoietin administration after myocardial infarction in mice attenuates ischemic cardiomyopathy associated with enhanced homing of bone marrow-derived progenitor cells via the CXCR-4/SDF-1 axis. FASEB J 2009;23:351-61, doi:10.1096/fj.08-109462.
3. Burger D, Lei M, Geoghegan-Morphet N, et al. Erythropoietin protects cardiomyocytes from apoptosis via up-regulation of endothelial nitric oxide synthase. Cardiovasc Res 2006;72:51-9, doi:10.1016/j.cardiores.2006.06.026.
4. Hirata A, Minamino T, Asanuma H, et al. Erythropoietin enhances neovascularization of ischemic myocardium and improves left ventricular dysfunction after myocardial infarction in dogs. J Am Coll Cardiol 2006;48:176-84, doi:10.1016/j.jacc.2006.04.008.
5. van der Meer P, Lipsic E, Henning RH, et al. Erythropoietin induces neovascularization and improves cardiac function in rats with heart failure after myocardial infarction. J Am Coll Cardiol 2005;46:125-33, doi:10.1016/j.jacc.2005.03.044.
6. Zaruba MM, Huber BC, Brunner S, et al. Parathyroid hormone treatment after myocardial infarction promotes cardiac repair by enhanced neovascularization and cell survival. Cardiovasc Res 2008;77:722-31, doi:10.1093/cvr/cvm080.
7. Bengel FM. Clinical cardiovascular molecular imaging. J Nucl Med 2009;50:837-40, doi:10.2967/jnumed.108.059246.
8. Stegger L, Hoffmeier AN, Schafers KP, et al. Accurate noninvasive measurement of infarct size in mice with high-resolution PET. J Nucl Med 2006;47:1837-44.
9. Bennink RJ, van den Hoff MJ, van Hemert FJ, et al. Annexin V imaging of acute doxorubicin cardiotoxicity (apoptosis) in rats. J Nucl Med 2004;45:842-8.
10. Sarda-Mantel L, Hervatin F, Michel JB, et al. Myocardial uptake of 99mTc-annexin-V and 111In-antimyosin-antibodies after ische-mia-reperfusion in rats. Eur J Nucl Med Mol Imaging 2008;35: 158-65, doi:10.1007/s00259-007-0559-2.
11. Thimister PW, Hofstra L, Liem IH, et al. In vivo detection of cell death in the area at risk in acute myocardial infarction. J Nucl Med 2003;44:391-6.
12. De Saint-Hubert M, Prinsen K, Mortelmans L, et al. Molecular imaging of cell death. Methods 2009;48:178-87, doi:10.1016/j.ymeth.2009.03.022.
13. Kenis H, van Genderen H, Bennaghmouch A, et al. Cell surface-expressed phosphatidylserine and annexin A5 open a novel portal of cell entry. J Biol Chem 2004;279:52623-9, doi:10.1074/jbc.M409009200.
14. National Institutes of Health. Guide for the care and use of laboratory animals. Bethesda (MD): National Institutes of Health; 1996. NIH publication no.: 85-23.
15. Wangler C, Wangler B, Lehner S, et al. A universally applicable 68Ga-labeling technique for proteins. J Nucl Med 2011;52:586-91, doi:10.2967/jnumed.110.082198.
16. Wollenweber T, Zach C, Rischpler C, et al. Myocardial perfusion imaging is feasible for infarct size quantification in mice using a clinical single-photon emission computed tomography system equipped with pinhole collimators. Mol Imaging Biol 2010;12:427-34, doi:10.1007/s11307-009-0281-5.
17. Mevorach D, Trahtemberg U, Krispin A, et al. What do we mean when we write "senescence, " "apoptosis, " "necrosis, " or "clearance of dying cells"? Ann N Y Acad Sci 2010;1209:1-9, doi:10.1111/j.1749-6632.2010.05774.x.
18. Campian ME, Verberne HJ, Hardziyenka M, et al. Serial noninvasive assessment of apoptosis during right ventricular disease progression in rats. J Nucl Med 2009;50:1371-7, doi:10.2967/jnumed.108.061366.
19. Hofstra L, Liem IH, Dumont EA, et al. Visualisation of cell death in vivo in patients with acute myocardial infarction. Lancet 2000; 356:209-12, doi:10.1016/S0140-6736(00)02482-X.
20. Kenis H, Zandbergen HR, Hofstra L, et al. Annexin A5 uptake in ischemic myocardium: demonstration of reversible phosphatidyl-serine externalization and feasibility of radionuclide imaging. J Nucl Med 2010;51:259-67, doi:10.2967/jnumed.109.068429.
21. Wolters SL, Corsten MF, Reutelingsperger CP, et al. Cardiovascular molecular imaging of apoptosis. Eur J Nucl Med Mol Imaging 2007;34 Suppl 1:S86-98, doi:10.1007/s00259-007-0443-0.
22. van Genderen H, Kenis H, Lux P, et al. In vitro measurement of cell death with the annexin A5 affinity assay. Nat Protoc 2006;1: 363-7, doi:10.1038/nprot.2006.55.
23. Kelly KJ, Sandoval RM, Dunn KW, et al. A novel method to determine specificity and sensitivity of the TUNEL reaction in the quantitation of apoptosis. Am J Physiol Cell Physiol 2003;284: C1309-18.
24. Dang AC, Kim HT. Chondrocyte apoptosis after simulated intraarticular fracture: a comparison of histologic detection methods. Clin Orthop Relat Res 2009;467:1877-84, doi:10.1007/s11999-009-0829-3.
25. Chen EQ, MacIntyre WJ, Go RT, et al. Myocardial viability studies using fluorine-18-FDG SPECT: a comparison with fluorine-18-FDG PET. J Nucl Med 1997;38:582-6.
26. Knesaurek K, Machac J. Comparison of 18F SPECT with PET in myocardial imaging: a realistic thorax-cardiac phantom study. BMC Nucl Med 2006;6:5, doi:10.1186/1471-2385-6-5.
27. Magota K, Kubo N, Kuge Y, et al. Performance characterization of the Inveon preclinical small-animal PET/SPECT/CT system for multimodality imaging. Eur J Nucl Med Mol Imaging 2011;38: 742-52, doi:10.1007/s00259-010-1683-y.
28. Doue T, Ohtsuki K, Ogawa K, et al. Cardioprotective effects of erythropoietin in rats subjected to ischemia-reperfusion injury: assessment of infarct size with 99mTc-annexin V. J Nucl Med 2008;49:1694-700, doi:10.2967/jnumed.107.050260.
29. Taki J, Higuchi T, Kawashima A, et al. Detection of cardiomyocyte death in a rat model of ischemia and reperfusion using 99mTc-labeled annexin V. J Nucl Med 2004;45:1536-41.
30. Dumont EA, Hofstra L, van Heerde WL, et al. Cardiomyocyte death induced by myocardial ischemia and reperfusion: measurement with recombinant human annexin-V in a mouse model. Circulation 2000;102:1564-8, doi:10.1161/01.CIR.102. 13.1564.
31. Kessler PD BB. Myoblast cell grafting into heart muscle: cellular biology and potential applications. Annu Rev Physiol 1999;61:219-42, doi:10.1146/annurev.physiol.61.1.219.
32. vom Dahl J, Eitzman DT, al-Aouar ZR, et al. Relation of regional function, perfusion, and metabolism in patients with advanced coronary artery disease undergoing surgical revascularization. Circulation 1994; 90: 2356-66. doi:10.1161/01.CIR.90.5.2356.